245 filings
Page 3 of 13
8-K
utze1dhka
5 Jun 23
Enveric Biosciences Receives Notice of Allowance from USPTO for EVM301 Series of Drug Candidates
8:00am
8-K
r7drmne z103jt
30 May 23
Enveric Biosciences Announces Poster Presentation at Canadian Neuroscience Meeting 2023
8:00am
8-K
ol3z dlrr73
24 May 23
Termination of a Material Definitive Agreement
8:00am
8-K
w2ht otig2
24 May 23
Regulation FD Disclosure
8:00am
8-K
xoz7ton
22 May 23
Regulation FD Disclosure
8:00am
8-K
3my9 6tb2zn0npge
19 May 23
Enveric Biosciences to Participate in 2023 BIO International Convention in Boston
8:00am
8-K
frtz395nopgd0ighsk
18 May 23
Enveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin
8:00am
8-K
5xd8gu64
13 Apr 23
Regulation FD Disclosure
8:30am
8-K
vxnu163
10 Apr 23
Enveric Biosciences to Participate in Benzinga Psychedelics Capital Conference
10:11am
8-K
iczd oxwof
3 Apr 23
Enveric Biosciences Reports Fourth Quarter and Year-End 2022 Corporate and Financial Results
4:51pm
8-K
fkz3z 6t5es3e
23 Mar 23
EB-373, a proprietary psilocin prodrug, is on track to start its first-in-human clinical trial in the fourth quarter of 2023
7:45am
8-K
w7rzdgs
21 Mar 23
Enveric Biosciences Establishes Australia-based Subsidiary to Accelerate its Lead Psilocin Prodrug Program Targeting Mental Health Indications
7:49am
8-K
ep8 nj23omo
14 Mar 23
Enveric Biosciences Announces Bioproduction Platform Using Novel Cane Toad Enzyme for Psychedelic-Inspired Drug Discovery
8:08am
8-K
ehcubiculi65zq575
28 Feb 23
Departure of Directors or Certain Officers
4:18pm
8-K
dh6ka8
23 Feb 23
Accomplished pharmaceutical industry leader brings to Enveric extensive experience in clinical operations, asset strategy and product development
7:33am
8-K
w6yr o4dm31g
28 Oct 22
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
joni 16je
24 Oct 22
Regulation FD Disclosure
8:58am
8-K/A
9tb08dhv63
6 Oct 22
Changes in Registrant's Certifying Accountant
5:00pm
8-K
szx0x6 6bw8n4lml3bi
23 Sep 22
Changes in Registrant's Certifying Accountant
5:00pm
8-K
naokzf5g6ys5
14 Sep 22
Regulation FD Disclosure
9:30am